عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

​Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    1
    2
    3
    4
    5
    6
    7
    ...
    11
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
B01AB05 ENOXA MEDIS BioTech Enoxaparin sodium - 4,000U Anti-Xa/0.4ml 4,000U Anti-Xa/0.4ml Injectable solution 755,239 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 300mg 300mg Injectable powder for concentrate for solution 2,501,241 L.L
B01AB05 ENOXAPARIN LEDRAXEN BioTech Enoxaparin sodium - 4000UI (40mg)/0.4ml 4000UI (40mg)/0.4ml Injectable solution 841,245 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 108mg 108mg Injectable solution 1,416,323 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 108mg 108mg Injectable solution 1,416,323 L.L
B01AB05 ENOMEX BioTech Enoxaparin sodium - 8000U Anti-Xa/0.8ml 8000U Anti-Xa/0.8ml Injectable solution 1,708,600 L.L
B01AB05 ENOXA MEDIS BioTech Enoxaparin sodium - 8,000U Anti-Xa/0.8ml 8,000U Anti-Xa/0.8ml Injectable solution 963,535 L.L
B01AB05 ENOMEX BioTech Enoxaparin sodium - 6000U Anti-Xa/0.6ml 6000U Anti-Xa/0.6ml Injectable solution 1,538,380 L.L
B01AB05 ENOXA MEDIS BioTech Enoxaparin sodium - 6,000U Anti-Xa/0.6ml 6,000U Anti-Xa/0.6ml Injectable solution 765,990 L.L
L04AB01 ENBREL BioTech Etanercept - 50mg 50mg Injectable solution 856,168 L.L
B01AB05 ENOXAPARIN LEDRAXEN BioTech Enoxaparin sodium - 6000UI (60mg)/0.6ml 6000UI (60mg)/0.6ml Injectable solution 854,684 L.L
L04AB01 ENBREL BioTech Etanercept - 50mg 50mg Injectable solution 856,168 L.L
L01XX02 ERWINASE BioTech Erwinia L-asparaginase - 10,000IU 10,000IU Injectable lyophilised powder for solution 271,088,947 L.L
L04AB01 ERELZI BioTech Etanercept - 50mg 50mg Injectable solution 904,040 L.L
L04AB01 ERELZI BioTech Etanercept - 50mg 50mg Injectable solution 798,816 L.L
L04AB01 ENBREL BioTech Etanercept - 25mg 25mg Injectable solution 12,005,564 L.L
B01AB05 ENOMEX BioTech Enoxaparin sodium - 2000U Anti-Xa/0.2ml 2000U Anti-Xa/0.2ml Injectable solution 662,962 L.L
L04AB01 ERELZI BioTech Etanercept - 25mg 25mg Injectable solution 12,454,611 L.L
B01AB05 ENOXA MEDIS BioTech Enoxaparin sodium - 2,000U Anti-Xa/0.2ml 2,000U Anti-Xa/0.2ml Injectable solution 388,370 L.L
L04AB01 ETANERREL BioTech Etanercept - 25mg/0.5ml 25mg/0.5ml Injectable solution 5,085,100 L.L
L04AB01 ETANERREL BioTech Etanercept - 50mg/ml 25mg/0.5ml Injectable solution 9,756,719 L.L
L01FE01 ERBITUX BioTech Cetuximab - 100mg/20ml 100mg/20ml Injectable solution 3,811,761 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 300mg 300mg Injectable powder for concentrate for solution 152,492,033 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 108mg 108mg Injectable solution 86,348,304 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 108mg 108mg Injectable solution 86,348,304 L.L
L04AB01 ERELZI BioTech Etanercept - 50mg 50mg Injectable solution 55,116,226 L.L
L04AB01 ERELZI BioTech Etanercept - 50mg 50mg Injectable solution 38,118,333 L.L
J05AF10 ENTECAVIR ARROW G Entecavir - 1mg 1mg Tablet, coated 7,804,483 L.L
J01FA01 ERYTHROMYCIN STEARATE G Erythromycin (steararte) - 500mg 500mg Tablet, scored 527,298 L.L
J05AF10 ENTECAVIR BIOGARAN G Entecavir - 1mg 1mg Tablet, coated 7,962,569 L.L
    1
    2
    3
    4
    5
    6
    7
    ...
    11
Sitemap
© Copyrights reserved to Ministry of Public Health 2024